This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked RPL6 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RPL6 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~32.7 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A07614 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A07614) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A07614) |
| Primary antibody | A07614 · 1:1000 (catalog A07614) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A07614) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A07614) |
RPL6 has a predicted mass of 32.7 kDa; its listed modifications could affect migration, but no shifted band is demonstrated.
| Single band near 32.7 kDa | Consistent with predicted RPL6 size; confirm identity with an RPL6 depletion control |
| Band near 32.7 kDa in a cytosolic fraction | Consistent with the reported cytosolic location of RPL6 |
| Band near 32.7 kDa in a polysome fraction | Consistent with detection of RPL6 on cytosolic polysomes |
| Band near 32.7 kDa in a rough ER fraction | Consistent with the reported rough ER association of RPL6 |
| Close doublet near 32.7 kDa | Could reflect modified RPL6 states; the listed modifications do not establish a visible doublet |
| UniProt predicted mass | Sets a reference of 32.7 kDa for RPL6 |
| N6-succinyllysine at Lys94 | May affect migration, but no visible size change is established |
| Phosphoserine at Ser127 | May affect migration, but no visible size change is established |
| N6-succinyllysine at Lys207 | May affect migration, but no visible size change is established |
| N6-acetyllysine at Lys239 | May affect migration, but no visible size change is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Insufficient detectable RPL6 or ineffective antibody detection | Check loading and transfer, then compare with a cytosolic or polysome fraction |
| Band higher than expected | A modified RPL6 state or an unrelated antibody target; neither is established | Check band identity with RPL6 depletion and compare treated and untreated samples where relevant |
| Band lower than expected | Possible protein breakdown or an unrelated antibody target | Prepare fresh lysate with protease inhibitors and check band identity by RPL6 depletion |
| Multiple bands | Possible modified RPL6 states or antibody cross-reactivity | Check which bands decrease after RPL6 depletion |
| Weak or no signal | Low loaded RPL6 amount or ineffective detection | Check loading, transfer and antibody conditions; compare a polysome-enriched fraction |
| Fragments below expected size | Possible degradation of RPL6 during preparation | Keep samples cold, use protease inhibitors and compare fresh lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Medium | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Not detected | Protein (IHC) | HPA → |
| Ovary | follicle cells | Not detected | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for RPL6, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A07614 is the sole listed anti-RPL6 antibody. It is reported reactive with human, mouse, and rat and has a Western blot image of extracts from various cell lines. The caption does not identify those cell lines or their species.
Which to pick: A07614 is the only listed option. Its WB image uses 25 µg of cell-line extract per lane and a 1:1000 primary dilution. Check its reported human, mouse, and rat reactivity against your intended sample.